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Background: Castration-resistant prostate cancer (CRPC) is refractory to chemo-radiotherapy.
Results: Transfection of the synthetic analog of dsRNA poly(I:C) simultaneously stimulates apoptosis and IFN- expression
through different pathways in androgen-independent prostate cancer (PCa) cells.
Conclusion: Dual parallel pathways triggered by distinct receptors activate direct and immunologically mediated antitumor
effects in advanced PCa.
Significance: The proapoptotic/immunoadjuvant poly(I:C)-Lipofectamine complexmay offer new therapeutic insights into CRPC.
Despite the effectiveness of surgery or radiation therapy for
the treatment of early-stage prostate cancer (PCa), there is cur-
rently no effective strategy for late-stage disease. New therapeu-
tic targets are emerging; in particular, dsRNA receptors Toll-
like receptor 3 (TLR3) and cytosolic helicases expressed by
cancer cells, once activated, exert a pro-apoptotic effect in dif-
ferent tumors. We previously demonstrated that the synthetic
analog of dsRNA poly(I:C) induces apoptosis in the androgen-
dependent PCa cell line LNCaP in a TLR3-dependent fashion,
whereas only a weak apoptotic effect is observed in the more
aggressive and androgen-independent PCa cells PC3 and
DU145. In this paper, we characterize the receptors and the sig-
naling pathways involved in the remarkable apoptosis induced
by poly(I:C) transfected by Lipofectamine (in-poly(I:C)) com-
pared with the 12-fold higher free poly(I:C) concentration in
PC3 and DU145 cells. By using genetic inhibition of different
poly(I:C) receptors,wedemonstrate the crucial role ofTLR3and
Src in in-poly(I:C)-induced apoptosis. Therefore, we show that
the increased in-poly(I:C) apoptotic efficacy is due to a higher
binding of endosomal TLR3. On the other hand, we show that
in-poly(I:C) binding to cytosolic receptors MDA5 and RIG-I
triggers IRF3-mediated signaling, leading uniquely to the up-
regulation of IFN-, which likely in turn induces increased
TLR3, MDA5, and RIG-I proteins. In summary, in-poly(I:C)
activates two distinct antitumor pathways in PC3 and DU145
cells: one mediated by the TLR3/Src/STAT1 axis, leading to
apoptosis, and the other one mediated by MDA5/RIG-I/IRF3,
leading to immunoadjuvant IFN- expression.
Prostate cancer (PCa)3 represents the second leading cause
of cancer death in men and develops as a result of the accumu-
lation of genetic and epigenetic alterations. PCa is initially
treated with removal of androgens; however, androgen deple-
tion is usually associated with the recurrence of metastatic and
more aggressive PCa termed “castration-resistant” or andro-
gen- and chemotherapy-insensitive (1). Data from the litera-
ture suggest that new therapeutic targets are emerging, and
among these targets, an important role is played by theToll-like
receptor (TLR) family (2). This family includes several mem-
brane-bound receptors that recognize pathogen-associated
molecular patterns and represents the first line of defense
against invading pathogens. TLRs transduce the signal through
MAPKs, NF-B, and IRF3 (interferon regulatory factor-3),
which induce the transcription of proinflammatory cytokines
and type I interferons (3). TLRs are expressed both by immune
cells and by cancer cells; thus, the use of specific TLR agonists
alone or in combination with standard chemo- or radiothera-
pies has been shown to have a valid anti-cancer activity in dif-
ferent in vitro or in vivo cancer models, and several molecules
have been tested in clinical trials (4). In particular, it is known
that the activation of Toll-like receptor 3 (TLR3) by the dsRNA
synthetic analog poly(I:C) has a proapoptotic and thus antitu-
moral effect in different tumors (5). It is well known that extra-
cellular dsRNA, produced as viral genome or genomic interme-
diate by dead infected cells, is endocytosed and recognized by
TLR3 (6), which is located on the endosomal membrane. TLR3
uses the adaptor protein TRIF (7), engaging the protein kinase
IKK, to activate the transcription factor NF-B and the protein
kinases TBK1/IKK- (8) to activate the transcription factors
IRF3 and IRF7 (9).Moreover, it has been demonstrated that the
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tyrosine kinase Src is activated by dsRNA, associates with
TLR3, and is essential for dsRNA-elicited IRF3 andSTAT1acti-
vation (10). In contrast, intracellular dsRNA produced by
viruses replicating in the cytoplasm is recognized by cytosolic
sensors, including double-stranded RNA-dependent protein
kinase (PKR) as well as RIG-I (retinoic inducible gene-I) and
MDA5 (melanoma differentiation-associated gene 5), which
are collectively called RIG-I-like helicases (RLHs) (11, 12). The
RLHs use mitochondrial membrane-bound protein, MAVS
(mitochondrial antiviral signaling protein; also known as IPS-1,
VISA, or Cardif), as an adaptor that recruits severalmembers of
the TRAF family proteins, which, in turn, activate the same
protein kinases and transcription factors as TLR3 (13–16).
These transcription factors drive the expression of type I inter-
feron genes and many interferon-stimulated genes, which are
essential for both direct virus elimination and immunologically
mediated antiviral defense (17). We previously demonstrated
that poly(I:C) (specific ligand of TLR3) induces apoptosis in the
androgen-dependent prostate cancer cell line LNCaP in a
TLR3-dependent fashion, whereas it has been observed to have
a weaker apoptotic effect in themore aggressive and androgen-
independent prostate cancer cell lines PC3 (18) and DU145
(19). Recently, Matsushima-Miyagi et al. (20) demonstrated
that non-replicating Sendai intracellular virus particles induce
cancer-selective apoptosis via the up-regulation of TRAIL and
Noxa downstream of the RIG-I/MAVS pathway in prostate
cancer cell lines. In this regard, we have recently demonstrated
that the encapsulation of poly(I:C) with three different formu-
lations of cationic liposomes was up to 10 times more efficient
than the free drug in eliminating both PC3 and DU145 meta-
static prostate cancer cells (21). In the present work, we ana-
lyzed the mechanisms involved in the induction of apoptosis
induced by poly(I:C) transfected by Lipofectamine (the most
commonly used transfection agent) compared with free
poly(I:C) in PC3 and DU145 cells. Here we demonstrate that,
when poly(I:C) is complexed with Lipofectamine, its delivery
into the cell is not directly to the cytosol, but, once internalized,
poly(I:C) first makes contact with endosomes, where TLR3 is
localized, and only subsequently is it released in the cytosol
where it interacts with cytosolic receptors. Consequently, we
aimed to dissect the signaling pathways triggered by both TLR3
and cytosolic receptors and their downstream biological
responses in two aggressive androgen-resistant PCa cell lines.
Altogether, our results highlighted dual distinct antitumor
pathways activated by transfected poly(I:C): one mediated by
TLR3, Src-dependent and leading to apoptosis, and the other
one mediated by the cytosolic receptors MDA5 and RIG-I,
IRF3-dependent, leading to up-regulation of MDA5, RIG-I,
TLR3, and IFN- production. Finally, we show that the higher
levels of apoptosis induced by in-poly(I:C) compared with ex-
poly(I:C) are dependent on different magnitude of TLR3 stim-
ulation due to a greater delivery in the endosomes rather than
to the trigger of distinct apoptotic pathways.
EXPERIMENTAL PROCEDURES
Cell Lines and Reagents—PC3 and DU145 cell lines, derived
fromhuman bone and brain prostate cancermetastasis, respec-
tively, were purchased from ATCC (Manassas, VA). PC3 cells
were maintained in RPMI medium, and DU145 cells were
maintained in minimum essential medium Eagle. Both media
were supplemented with 2 mM L-glutamine, 100 IU/ml penicil-
lin-streptomycin, 1 mM sodium pyruvate, 10 mM Hepes, 1.5
mg/liter sodium bicarbonate, and 10% fetal bovine serum (FBS)
(Sigma-Aldrich).
Poly(I:C), poly(I:C)-rhodamine, TRIF inhibitor peptide (Pep-
inh-TRIF), 2-aminopurine, and BX795 were from Invivogen
(SanDiego, CA). SU6656, SB203580, SP600125, and benzyloxy-
carbonyl-VAD-fluoromethyl ketone were from Calbiochem
(Merck KGaA). Propidium iodide and 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) were from
Sigma-Aldrich. IKK- kinase inhibitor II was from Biovision
(Milpitas, CA). Early and late endosomes-GFP were from
Invitrogen.
Caspase Activity Assay—PC3 and DU145 cells were treated
with poly(I:C) alone or in combinationwith Lipofectamine, and
after 48 and 72 h, cells were detached with trypsin/EDTA and
centrifuged at 1000 rpm for 5 min at 4 °C. The pellet was resus-
pended in 50l of cell lysis buffer provided by caspase-8 and -9
activity kits (Biovision). After determination of protein concen-
tration, 150 g of protein were incubated in 96-plate well with
reaction buffer and IETD-p-nitroanilide substrate (caspase-8)
or LEHD-p-nitroanilide substrate (caspase-9). After 2 h of incu-
bation at 37 °C the samples were read at 405 nm. The -fold
increase in caspase activity was determined by comparing the
levels of treated samples with the level of the control.
Apoptosis Assays—For propidium iodide (PI) staining, cells
were detached with trypsin/EDTA, washed twice with cold
phosphate-buffered saline (PBS), and then fixed in 70% ethanol
for 24 h. After washing three times with PBS, cells were incu-
bated with 50 g/ml PI for 3 h at room temperature before
FACS analysis by a Coulter Epics XL flow cytometer (Beckman
Coulter, Fullerton, CA). Cells were gated using forward versus
side scatter to exclude debris. The percentage of cells in the
sub-G1 compartment was considered apoptotic (using Win-
MDI software).
Mitochondrial Membrane Potential Measurement—Dissipa-
tion of the mitochondrial membrane potential is a hallmark for
intrinsic apoptosis. Mitochondrial membrane potential was
analyzed using JC-1 dye staining (Immunological Sciences).
The cationic dye JC-1 stains the mitochondria of healthy cells
red and apoptotic cells green. JC-1 (5mg/ml) stock solutionwas
diluted in RPMI, and 1  106 cells were diluted in JC-1/RPMI
medium and incubated for 15 min in the dark at 37 °C. Cells
were washed twice in 1 PBS and then analyzed for red and
green fluorescence by flow cytometry.
Analysis of Cell Viability—For the MTT assay, 2  104 PC3
and DU145 cells were seeded on 96-well plates. After 24 h, cells
were treated with poly(I:C) and Lipofectamine at increasing
doses for 24 and 48 h. Cell viability was assessed by MTT
(Sigma-Aldrich), as described (22). Briefly, PC3 and DU145
cells were seeded on 96-well plates and after 24 h were treated
with poly(I:C) complexed with Lipofectamine for 24 and 48 h.
MTT was added to each well at the a concentration of 0.5
mg/ml, and after 4 h of incubation at 37 °C, the formazan salt
was dissolved with 100 l of isopropyl alcohol. The absorbance
of each well was measured with an ELISA reader at 550-nm
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wavelength, and the viability was calculated for each treatment
as “OD of treated cells/OD of control cells” 100.
Western Blotting—Cell lysates were prepared in cell lysis
buffer (Cell Signaling, Danvers, MA). Protein concentration
was determined by the microbicinchoninic acid method
(Pierce).
Equal amounts of proteins (40 g) were subjected to SDS-
PAGE and transferred onto nitrocellulosemembrane saturated
with 5% nonfat dry milk in Tris-buffered saline with 0.1%
Tween 20. Membranes were incubated with primary antibody
and subsequently with horseradish peroxidase-conjugated sec-
ondary antibody for 1 h at room temperature.Membranes were
washed with Tris-buffered saline with 0.1% Tween 20 and
developedusing the chemiluminescence system (ECLAdvance,
Amersham Biosciences). The sources of primary antibodies
were as follows: cleaved caspase-3, TLR3, MDA5, RIG-I,
MAVS, phospho-IRF3, phospho-JNK, and phospho-p38 from
Cell Signaling (Danvers, MA); IRF3 from Santa Cruz Biotech-
nology, Inc.; phospho-PKR and phospho-STAT1 Tyr701 from
Abcam (Cambridge, UK). -Actin was from Sigma-Aldrich.
Secondary antibodies were horseradish peroxidase-conjugated
goat anti-mouse or anti-rabbit (Bio-Rad).
Transfection—Poly(I:C) was transfected at a concentration of 2
g/ml using 4g/ml Lipofectamine (Invitrogen) according to the
manufacturer’s protocol. siRNAs were transfected with Oligo-
fectamine or Lipofectamine 2000 (Invitrogen) for 4 h: siMAVS
targeted sequence, 5-GAAUGCCUCUCCUGUUGCA-3;
siIRF3 targeted sequence, 5-UUGACCAUCACGAGCCU-
CUUGGUCCAC-3; siMDA5 targeted sequence, 5-GUGG-
AAUACCCAUUCGACAUCUUUCUU-3; siRIG-I targeted
sequence, 5-UAAGGUUGUUCACAAGAAUCUGUGG.
TLR3 knockdown in PC3 and DU-145 cells was achieved by
using TLR3-dominant negative plasmid (DN-TLR3, pZERO
bearing the human TLR3TIR gene; InvivoGen).
Stably transfected DN-TLR3 PC3 and control P-PURO PC3
cells were obtained as described previously (23). DU145 cells
were transiently transfected with DN-TLR3 and control
P-PURO for 48 h, and then cells were treated with poly(I:C)
alone or in combination with Lipofectamine. Total DNA was
extracted using phenol/chloroform/isoamyl alcohol (25:24:1).
To confirm the presence of DN-TLR3 plasmid, semiquantita-
tive polymerase chain reaction (PCR)was performed using 1g
of total DNA, specific primers (10 M) (forward, 5-
GAACGTTCTTTTTCGCAACG-3; reverse, 5-CTCATTG-
TGCTGGAGGTTCA-3), and 1.5 units of TaqDNA polymer-
ase (Invitrogen). Data were normalized for the expression of
-actin.
Luciferase Assay—The IFN-pGL3 luciferase reporter was
kindly provided by Professor John Hiscott (Vaccine and Gene
Therapy Institute of Florida, Port St. Lucie, FL) (24).
One day after plating (2.5  105 cells/ml), cells were trans-
fected by means of Lipofectamine Plus reagent (Invitrogen)
with IFN-pGL3. Transfection was stopped after 5 h by chang-
ing medium with 10% FBS. After 18 h, cells were stimulated
with 2 g/ml poly(I:C) complexed with 4 g/ml Lipofectamine
for 3 h, followed by lysis using specific buffer (Promega, Madi-
son, WI). Luciferase activity was assayed with a Berthold lumi-
nometer using a luciferase assay kit (Promega), according to the
manufacturer’s instructions. Data were normalized to protein
concentration.
Laser-scanning ConfocalMicroscopy—PC3 cells were treated
with rhodamine-labeled poly(I:C) at 2 g/ml plus Lipo-
fectamine or rhodamine-labeled ex-poly(I:C) (25 or 2g/ml) at
the indicated times in the presence of GFP-labeled early endo-
some marker Rab5a or GFP-labeled late endosome marker
Rab7a. Then cells were fixed in 4%paraformaldehyde in PBS for
20min. Laser-scanning confocal microscopy experiments were
performed with a Leica TCS SP2 (Leica Microsystems Heidel-
berg GmbH). Analysis of the co-localization between endo-
somes and poly(I:C) was performed usingManders’ colocaliza-
tion coefficient (25).
Statistical Analysis—Statistical differences were determined
either by Student’s t test for paired samples or by one-way anal-
ysis of variance followed by Student’s t test with Bonferroni’s
correction. p 0.05 was considered significant. Densitometric
analysis was performed using ImageJ software (National Insti-
tutes of Health).
RESULTS
Caspase-dependent Apoptosis of Androgen-resistant PCa
Cells Is Strongly Enhanced by Transfected Poly(I:C) Compared
with Extracellular Poly(I:C)—A common strategy to lower the
required dosage of antitumor drugs and improve their effec-
tiveness is encapsulation (26).
Strong cytotoxic effects induced by poly(I:C)-cationic lipo-
some complexes on various malignant epithelial cells were
observed previously (27, 28). Because the PC3 and DU145 cell
lines are two models of androgen-insensitive very aggressive
metastatic PCa and they are weakly sensitive to high doses of
free poly(I:C) (ex-poly(I:C)) (18, 19), PC3 and DU145 cells were
stimulated with in-poly(I:C) and subjected to cell viability anal-
ysis by an MTT assay. We observed a strong reduction of cell
viability in both cell lines (data not shown). To investigate
whether poly(I:C) transfection is able to induce apoptosis, PC3
and DU145 cells were treated for 48 h with increasing doses of
in-poly(I:C) and then stained with PI and subjected to cell cycle
analysis by flow cytometry. The histograms in Fig. 1A show a
dose-dependent increase of apoptosis in both cell lines with the
highest efficiency at 2 g/ml poly(I:C) in combination with a
double dose of Lipofectamine, compared with the untrans-
fected poly(I:C) at the same concentration and even compared
with a 12-fold higher poly(I:C) concentration (25 g/ml). A
Western blot for cleaved caspase-3 further confirmed the
higher rate of apoptosis after in-poly(I:C) compared with ex-
poly(I:C) in both cell lines (Fig. 1, B and C). The two main
branches of apoptosis, the intrinsic and the extrinsic pathways,
are triggered, respectively, by the activation of caspase-9 and
caspase-8 (29). Therefore, to clarify the nature of apoptosis
caused by poly(I:C), we investigated caspase-8 and -9 activity
with colorimetric assays. As shown in Fig. 1D, in-poly(I:C) is
able to induce a significant activation of caspase-8 (48 h) and -9
(72 h) in both cell lines, whereas ex-poly(I:C) treatment acti-
vates only caspase-8. The caspase involvement in in-poly(I:C)-
induced apoptosis was confirmed by using the broad spectrum
caspase inhibitor benzyloxycarbonyl-VAD-fluoromethyl
ketone (z-VAD) (Fig. 1E). Because changes in mitochondrial
TLR3 and SrcMediate Apoptosis Independently of IRF3
5472 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 9•FEBRUARY 27, 2015
 at D
IP B
IO
TECN
O
LO
G
IE CELLU
LA
 on M
arch 21, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
outer membrane permeability are critical to the progression of
the intrinsic apoptotic pathway, we determined whether in-
poly(I:C) treatment was able to induce mitochondria depolar-
ization by using a JC-1 assay. We treated PC3 and DU145 cells
with in-poly(I:C) at the indicated times; subsequently, cells
were subjected to flow cytometry analysis to evaluate the per-
centage of depolarized-positive cells. Fig. 1F shows that in PC3
cells, poly(I:C) transfection induces mitochondrial depolariza-
tion starting from 16 h up to the maximum effect at 72 h,
whereas in DU145 cells, the effect is delayed, starting from 48 h
after in-poly(I:C) treatment, with the maximum effect after
72 h.
TLR3 Plays an Essential Role in Poly(I:C)-induced
Apoptosis—To investigate which receptor is implicated in in-
poly(I:C)-induced apoptosis, we first evaluated the implication
of PKR, which has been demonstrated to be an active player in
apoptosis induced by transfected dsRNA (30). Specific PKR
inhibitor 2-aminopurine in combination with in-poly(I:C) does
not affect apoptosis (data not shown). Because the RNA heli-
casesMDA5 and RIG-I function as cytoplasmic sensors of viral
RNA (12), we investigated MDA5 and RIG-I involvement in
in-poly(I:C)-induced apoptosis. We first evaluated this by
Western blot MDA5 and RIG-I protein levels, and, as shown in
Fig. 2A, in-poly(I:C) induces up-regulation of these receptors in
FIGURE 1. Effects of poly(I:C) transfection on PC3 and DU145 cell death. A, sub-G1 analysis after PI staining of PC3 and DU145 cells stimulated for 48 h as
indicated. Details of PI staining assay are described under “Experimental Procedures.” Results representmeans from three independent experiments with S.D.
(error bars). The exact p values are reported versus respective controls (Student’s paired t test): *, p 0.05; **, p 0.01. B, Western blot analysis for cleaved (cl.)
caspase-3 ofwhole cell lysates obtained fromPC3 andDU145 cells treatedwith poly(I:C) at 25g/ml added inmedium (ex-poly(I:C)) or poly(I:C) at 2g/ml plus
4g/ml Lipofectamine (in-poly(I:C)) for 48h.Datawerenormalized against-actin. Data shownare froma typical experiment repeated three timeswith similar
results. C, the histograms represent the densitometric values (mean S.D.) of protein levels from three different blots for cleaved caspase-3, calculated as the
-fold increase in inductionby comparing thevaluesofpoly(I:C)-treatedwith thoseof untreated cells (set arbitrarily at 1). Valueswerenormalizedagainst-actin
density values (Student’s paired t test): *, p  0.05; **, p  0.01. D, PC3 and DU145 cells were treated with ex-poly(I:C) or in-poly(I:C) and then subjected to
caspase-8or -9 activity assays following themanufacturer’s protocol. E, PC3andDU145were treatedwith in-poly(I:C) aloneor in combinationwithpan-caspase
inhibitor benzyloxycarbonyl-VAD-fluoromethyl ketone (z-VAD) at 20M for 48 h, and then cells were subjected to cell cycle analysis. The histograms represent
themean S.D. of three independent experiments (Student’s paired t test; **, p 0.01). F, JC1 assay on PC3 andDU145 cells. FL-1, flow cytometer channel for
mitochondrial depolarization (percentage of positive cells). Details of the assays are described under “Experimental Procedures.” Results represent the mean
from three experiments with S.D. (error bars). The exact p values are reported versus the respective controls (Student’s paired t test): *, p 0.05; **, p 0.01.
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both cell lines, even though the underlying kinetics differ. To
determine RNA helicase implication in in-poly(I:C)-induced
apoptosis, we employed the siRNA approach.We confirmed by
Western blot the silencing of MDA5 and RIG-I after using spe-
cific siRNAs in both cell lines (Fig. 2B). In in-poly(I:C)-treated
cells, MDA5 and RIG-I knockdown versus control siRNA
cells were shown not to significantly reduce apoptosis in the
two cell lines, as assayed by PI incorporation (Fig. 2, C
and D).
Because both helicases share the common downstream
adapter MAVS (31), we silenced MAVS with specific siRNA
in combination with in-poly(I:C) treatment in PC3 cells, and
cell cycle analysis demonstrated that MAVS inhibition does
not affect the apoptotic rate induced by in-poly(I:C) treat-
ment (Fig. 2E).
Afterward, we hypothesized a possible role of TLR3 in poly(I:
C)-induced apoptosis because data from the literature suggest
that when poly(I:C) is internalized into cationic liposomes,
once it enters into the cell, itmaymake contactwith endosomes
and then be carried to the cytoplasm (32, 33). We initially eval-
uated the TLR3 protein expression. Fig. 3A shows that in both
PCa cell lines, TLR3 is up-regulated upon in-poly(I:C) stimula-
tion in a time-dependentmanner.We have previously reported
in PC3 cells a low rate of TLR3-dependent apoptosis induced by
ex-poly(I:C) (23). In order to determine whether TLR3 plays a
role also in in-poly(I:C)-induced apoptosis, PC3 cells stably
transfected with TLR3-dominant negative plasmid (DN-TLR3)
and control plasmid (P-PURO) were treated with ex-poly(I:C)
(as a control) or in-poly(I:C) and then subjected to cell cycle
analysis. As shown in Fig. 3B, the apoptotic rate was completely
reverted in DN-TLR3 PC3 cells after extracellular poly(I:C)
treatment as expected, but, surprisingly, it was also strongly
reduced after in-poly(I:C) treatment. Similarly, a marked apo-
ptosis inhibition was obtained when DU145 cells were tran-
siently transfected with DN-TLR3 plasmid (Fig. 3C) or were
treated with Pepinh-TRIF to block TLR3 signal transduction
(data not shown), suggesting a crucial role for TLR3 in
in-poly(I:C)-dependent apoptosis in both PCa cell lines. PCR
analysis with specific primers in Fig. 3, D and E, shows the
presence of the pZERO-TLR3TIR plasmid in DN-TLR3-
FIGURE 2.MDA5, RIG-I, andMAVSarenot implicated in apoptosis inducedby transfectedpoly(I:C).A, time course analysis ofMDA5 andRIG-I assessedby
Western blot of whole cell lysates obtained from PC3 and DU145 cells treated with in-poly(I:C). Data were normalized against -actin. B, silencing of MDA5 or
RIG-I was evaluated byWestern blot analysis. PC3 and DU145 cells were treated with siRNA specific for MDA5 or RIG-I (siMDA5 or siRIG-I) or with control siRNA
() for 48 h. Subsequently, cells were treated with in-poly(I:C) for 48 h. Data were normalized against -actin. C and D, PC3 and DU145 cells were treated with
siMDA5 (C) or siRIG-I (D) or with control siRNA (NT) and subsequently with in-poly(I:C) for 48 h and then subjected to cell cycle analysis after PI incorporation.
The histograms represent themean S.D. (error bars) of the percentage of apoptotic cells of three independent experiments. The differences betweenNT and
siMDA5 or siRIG-I are not significant. E, the histograms represent the apoptotic rate of PC3 treated with siMAVS or NT in combination of in-poly(I:C) after PI
incorporation. The differences between NT and siMAVS are not significant. The histograms represent the mean S.D. of the percentage of apoptotic cells of
three independent experiments. Data in A and B are representative of three Western blots from three independent experiments.
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PC3 and in DN-TLR3-DU145 cells (see “Experimental
Procedures”).
Transfection Strongly Increases Poly(I:C) Uptake and Endo-
somal Localization in Androgen-resistant PCa Cells—To dem-
onstrate that the stronger apoptosis induced by in-poly(I:C)
compared with ex-poly(I:C) is associated with higher TLR3
stimulation rather than with the activation of different recep-
tors, we first verified to what extent poly(I:C) encapsulation by
Lipofectamine improves its uptake by PC3 andDU145 cells. For
this purpose, both cell lines were treated with rhodamine-la-
beled ex-poly(I:C), alone at 25 g/ml, or with in-poly(I:C) at 2
g/ml and then subjected to flow cytometric analysis. Strik-
ingly, after 6 h of in-poly(I:C) treatment, the mean of rhoda-
mine fluorescence rose up to about 60 compared with 10 after
ex-poly(I:C) at 25 g/ml, indicating a 6-fold increase in
poly(I:C) uptake by transfection compared with a 12-fold
higher dosage of ex-poly(I:C) (Fig. 4A). Subsequently, in order
to assess if in-poly(I:C) comes into contact with endosomes, we
performed confocal laser-scanning microscopy experiments in
PC3 cells treated with rhodamine-labeled poly(I:C), alone or in
combination with Lipofectamine, in the presence of GFP-la-
beled early endosome marker (fluorescent protein signal pep-
tide targeting Rab5a). Interestingly, despite poly(I:C)/endo-
some co-localization after both treatments, in-poly(I:C) was
localized in early endosomes with much more efficiency even
than ex-poly(I:C) at 25g/ml (Fig. 4B). To quantify the amount
of colocalization between the red and green signals at different
times of treatment, we used Manders’ correlation coefficient
(Fig. 4C), which suggests a high and similar colocalization
under all conditions, despite the different timing and fluores-
cence intensities upon different treatments. Moreover, there is
no significant co-localization of in-poly(I:C) with the late endo-
some marker Rab7a (data not shown).
IRF3 and IFN- Are Implicated in RLH Up-regulation but
Not in Apoptosis Induced by Transfected Poly(I:C)—After dem-
onstrating the key role of TLR3 in in-poly(I:C)-induced apopto-
sis, we analyzed its downstream pathways. TLR3 engagement
by ligand triggers the activation of IRF3, leading to induction of
type I IFNs and other inflammatory cytokines (17). IRF3 medi-
ates cytotoxic activity of poly(I:C)-cationic liposome LIC-101
complex against HeLa cells (34). In the present work, we
hypothesized the involvement of IRF3 in TLR3-mediated apo-
ptosis also in PC3 and DU145 cells. We first evaluated IRF3
activation assayed by detection of phosphorylated IRF3. As
shown in Fig. 5A, IRF3 phosphorylation increases after
in-poly(I:C) in a time-dependent manner in both cell lines. To
investigate the role of IRF3 activation in apoptosis, we first used
BX795, a pharmacological inhibitor of TBK1/IKK-, to inhibit
IRF3 phosphorylation induced by in-poly(I:C) (Fig. 5B). PC3
and DU145 cells were treated with in-poly(I:C) alone and in
combination with BX795, and then cells were subjected to cell
cycle analysis after PI incorporation. As shown in Fig. 5C, in-
FIGURE 3.TLR3 is crucial inpoly(I:C)-inducedapoptosis.A, time course analysis byWestern blot for TLR3onwhole cell lysates obtained fromPC3 andDU145
cells treated with in-poly(I:C). Data are representative of three Western blots from three independent experiments. Data were normalized against -actin. B,
PC3 cells stably transfected with TLR3 dominant negative (DN-TLR3) and control plasmid (P-PURO) were treated with in-poly(I:C) or ex-poly(I:C) for 48 h and
then subjected to cell cycle analysis after PI incorporation. C, DU145 cells were transiently transfectedwith DN-TLR3 or P-PURO, stimulatedwith in-poly(I:C) or
ex-poly(I:C) for 48 h, and then subjected to cell cycle analysis. Results in B and C represent themean from three independent experiments with S.D. (error bars).
The exact p values are reported versus respective controls (Student’s paired t test): **, p  0.01. D and E, PC3 and DU145 cells transfected with DN-TLR3 or
P-PURO were subjected to total DNA extraction, and the presence of the DN-TLR3 plasmid was assessed using PCR with specific primers (described under
“Experimental Procedures”). Nontransfected cells were used as negative control. -Actin was used as a control for equal amounts of DNA loaded.
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poly(I:C)-induced apoptosis was not inhibited in the presence
of BX795. This finding was confirmed after IRF3-specific
down-regulation by siRNA (Fig. 5D), demonstrating that IRF3
is not implicated in in-poly(I:C)-induced apoptosis in PC3 and
DU145 cell lines. Because it has been reported that the phos-
phorylation site at Ser-396 of the IRF3 regulatory domain is
directly targeted by IKK- (35), we used the IKK- kinase inhib-
itor II, a benzimidazole analog. This molecule acts as a selective
inhibitor of IKK- kinase and allows us to discriminate the role
of TBK1 and IKK- in IRF3 phosphorylation and in in-poly(I:
C)-induced apoptosis.Data in Fig. 5E show that IRF3phosphor-
ylation was abolished by IKK-, whereas in-poly(I:C)-induced
apoptosis was completely unaffected (Fig. 5F).
Phosphorylated IRF3 becomes active and translocates to the
nucleus, where it operates as a transcriptional factor inducing
antiviral genes as type I IFNs, which are also critical regulators
of NK cell activation and have antitumor activity (36). In this
regard, to confirm the canonical role of IRF3 in IFN type I
induction, we transfected PC3 cells with a plasmid containing
luciferase under the IFN- promoter and assayed the luciferase
activity after poly(I:C) alone and in combination with the IRF3
inhibitor BX795 for 3 h. DU145 cells were not tested because
they have been described as not being able to produce IFN type
I after poly(I:C) treatment (20). The pretreatment with BX795
abrogates the induction of IFN- transcription, demonstrating
the key role of IRF3 in the activation of the IFN- promoter
FIGURE 4. Enhancement of poly(I:C) uptake in PC3 and DU145 cells by transfection and in-poly(I:C) co-localization with early endosomes. A, PC3 and
DU145 cells were treated with in-poly(I:C)-rhodamine or ex-poly(I:C)-rhodamine labeled for 6 h and then subjected to flow cytometry analysis to evaluate the
fluorescence intensity of rhodamine-positive cells. Results are presented as mean range. a.u., arbitrary units. B, confocal laser-scanning microscopy of PC3
cells treated with rhodamine-labeled poly(I:C) at 2 g/ml plus Lipofectamine (in-poly(I:C)) or rhodamine-labeled ex-poly(I:C) (25 or 2 g/ml) at the indicated
times in the presence of GFP-labeled early endosomes marker Rab5a. Images are representative of three independent experiments. C, the histograms
representManders’ coefficientmeasured as the amount of fluorescence of the co-localizing objects in each component, which is dependent on the intensities
of the signals (n 5 or 10 cells/experiment). Error bars, S.D.
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(Fig. 6A). Moreover, we analyzed whether IRF3 was involved in
in-poly(I:C)-induced up-regulation of MDA5, RIG-I, and
TLR3. To this purpose, PC3 and DU145 cells were treated with
in-poly(I:C) alone or combined with BX795 and then subjected
to Western blot analysis for the evaluation of expression of the
three dsRNAreceptors. Fig. 6B shows that IRF3 inhibition abol-
ished the up-regulation of MDA5, RIG-I, and TLR3. To clarify
which receptor(s) trigger IRF3 activation in ourmodels, we per-
formed Western blot analysis for phospho-IRF3 in PC3 and
DU145 cells that had undergone siRNA-mediated MDA5 and
RIG-I knockdown. MDA5 siRNA abrogated IRF3 phosphory-
lation upon in-poly(I:C) stimulation in both cell lines (Fig. 6C),
whereas nonfunctional RIG-I impaired IRF3 phosphorylation
only in DU145 cells (Fig. 6D), suggesting that MDA5 alone or
together with RIG-I transduces through IRF3, which in turn
triggers IFN- production.
After demonstrating that in-poly(I:C)-apoptosis is IRF3-in-
dependent but is accompanied by IFN- increased expression,
we evaluated whether IFN- mediates in an autocrine fashion
in-poly(I:C)-triggered apoptosis, as described previously in dif-
ferent cancer cell lines (2, 37, 38). With this aim, we blocked
type I interferon receptor (IFNR-1) by a neutralizing antibody,
FIGURE 5. IKK--dependent IRF3 activation is not implicated in apoptosis induced by transfected poly(I:C) in both cell lines. A, Western blot analysis of
phosphorylated IRF3 (P-IRF3) of whole cell lysates obtained fromPC3 andDU145 cells after in-poly(I:C) treatment at the indicated times. Datawere normalized
against total IRF3. B, PC3 and DU145 cells were treated with in-poly(I:C) alone or in combination with BX795, and then cell lysates were subjected to Western
blot analysis to confirm phospho-IRF3 inhibition. Data were normalized against total IRF3. C, PI staining of PC3 and DU145 cells after 48 h of treatment with
in-poly(I:C) alone or in combination with BX795. The histograms represent the mean  S.D. (error bars) of the apoptotic cell percentage obtained in three
independent experiments.D, PC3 and DU145 cells were treated with siRNA specific for IRF3 (siIRF3) or with control siRNA (NT) for 72 h. Cells were treated with
in-poly(I:C) for 48 h and then subjected to cell cycle analysis after PI incorporation. The histograms represent the mean S.D. of the percentage of apoptotic
cells of three independent experiments. The differences between NT and siIRF3 are not significant. E, PC3 and DU145 cells were treatedwith in-poly(I:C) alone
or in combination with IKK- kinase inhibitor, and then whole cell lysates were subjected to Western blot analysis to confirm phospho-IRF3 inhibition. Data
werenormalizedagainst-actin. F, PI stainingofPC3andDU145cells after 48hof treatmentwith in-poly(I:C) aloneor in combinationwith IKK- kinase inhibitor
(inh.). The histograms represent the mean  S.D. of the apoptotic cell percentage obtained in three independent experiments. Data in A, B, and E are
representative of three Western blots from three independent experiments.
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and we assessed apoptosis rate after in-poly(I:C) treatment in
PC3 cells. Fig. 6E shows no effect of IFNR-1 on in-poly(I:C)-
induced apoptosis. The inhibitory effect of the antibody was
tested by evaluating STAT1 phosphorylation, which is a down-
stream signal of type I IFNR activation. STAT1 phosphoryla-
tion following in-poly(I:C) stimulation was inhibited by IFNR-
neutralizing antibody, confirming the functionality of the
antibody (Fig. 6F). As described in various cell types, type I
interferons produced upon poly(I:C) stimulation can act in an
autocrine manner, thereby increasing dsRNA receptor expres-
sion (39). To test this possibility in PC3 cells, we assessed
dsRNA receptor protein levels after in-poly(I:C) treatment in
combination with IFNR-neutralizing antibody. Fig. 6G shows
that the up-regulation of MDA5, RIG-I, and TLR3 induced by
in poly(I:C) was abolished in IFNR knockdown conditions.
Signaling Pathways Implicated in Apoptosis Induced by
Transfected Poly(I:C)—After excluding the involvement of
IFN- in mediating in-poly(I:C)-triggered apoptosis in PC3
cells, we investigated the pathways directly activated by
poly(I:C) transfection. TLR3 stimulation triggers activation of
MAPKs (17). We then investigated the role of MAPKs in in-
poly(I:C)-induced apoptosis because we have previously dem-
onstrated their role in apoptosis induced by TLR3-dependent
ex-poly(I:C) (18).With this purpose, we first evaluated JNK and
p38 activation after in-poly(I:C) treatment. As shown in Fig. 7A,
in-poly(I:C) stimulation induces activation of JNK and p38 in a
time-dependent manner in both cell lines. Afterward, to evalu-
ate their implication in apoptosis, we used the specific pharma-
cological inhibitors SP600125 for JNK and SB203580 for p38.
Cells were subjected to cell cycle analysis after PI incorporation,
and the histograms in Fig. 7B demonstrate that the apoptotic
rate induced by in-poly(I:C) was strongly reduced in the pres-
ence of JNK and/or p38 inhibitors in both cell lines, demon-
strating their essential role in the apoptotic pathway. By using
stably transfected DN-TLR3 PC3 cells and Pepinh-TRIF-
treated DU145 cells, we observed a significant inhibition of in-
poly(I:C)-induced JNK and p38 phosphorylation in transfected
DN-TLR3 PC3 cells versus P-PURO-PC3 cells and Pepinh-
FIGURE 6. IRF3 is implicated in the induction of interferon-, MDA5, RIG-I, and TLR3 expression. A, PC3 cells transiently transfected with IFN-pGL3-luc
plasmidwere treatedwith in-poly(I:C) alone or in combinationwith BX795 for 3 h and then subjected to a luciferase assay. Interferon- expressionwas assayed
by using the p-IFN-pGL3 luciferase reporter described under “Experimental Procedures.” The histograms represent the -fold induction of IFN expression
calculated from the mean  S.D. (error bars) of luciferase intensity obtained in three independent experiments. The exact p values are reported versus
respective controls (Student’s paired t test): **, p 0.01. B, Western blot analysis for phospho-IRF3, MDA5, RIG-I, and TLR3 of whole cell lysates obtained from
PC3andDU145 cells treatedwith in-poly(I:C) aloneor in combinationwith BX795 for 24h.C andD,Westernblot analysis for phosphorylated IRF3 (P-IRF3) of cell
lysates obtained from PC3 and DU145 cells treated with in-poly(I:C) after MDA5/RIG-I siRNAs or scrambled siRNA (). E, PI staining of PC3 cells treated with
in-poly(I:C) alone or in combination with IFNR-neutralizing antibody (IFNR Ab) for 48 h. The histograms represent the mean  S.D. of the percentage of
apoptotic cells obtained in three independent experiments. F, time course analysis of phosphorylated STAT1 (P-STAT1) assessed byWestern blot of whole cell
lysates from PC3 cells treated with in-poly(I:C) alone or in combination with IFNR-neutralizing antibody. G, Western blot analysis for MDA5, RIG-I, and TLR3 of
whole cell lysatesobtained fromPC3cells treatedwith in-poly(I:C) aloneor in combinationwith IFNR-neutralizingantibody for 24h.Data inB,C,D, F, andGwere
normalized against -actin and are representative of three Western blots from three independent experiments.
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TRIF-treated DU145 cells versus control DU145 cells in both
PCa cell lines (Fig. 7C).
Src and STAT1 Involvement in TLR3-dependent Apoptotic
Signaling—It has been demonstrated that TLR3 signaling
involves the proto-oncoprotein Src, which plays an essential
role for dsRNA-elicited STAT1 and IRF3 activation (10). To
investigate the role of Src in in-poly(I:C)-induced apoptosis,
PC3 and DU145 cells were pretreated with the specific Src
pharmacological inhibitor SU6656, prior to in-poly(I:C) stimu-
lation. In both cell lines, apoptosis was markedly decreased in
the presence of in-poly(I:C) plus SU6656 (Fig. 8A). Therefore,
we assayed STAT1 phosphorylation following in-poly(I:C)
treatment. Data in Fig. 8B show that STAT1 was rapidly acti-
vated, starting from 15 min after in-poly(I:C) stimulation in
both cell lines, and that its phosphorylation wasmore extended
in DU145 cells than in PC3 cells. SU6656 completely reverted
STAT1 activation in both cell lines. Interestingly, IRF3 phos-
phorylation induced by in-poly(I:C) is not affected by SU6656
(Fig. 8C). In order to evaluate whether Src also influences JNK
andp38activation,wetestedSU6656onJNKandp38phosphor-
ylation. As shown in Fig. 8D, Src inhibition does not decrease
JNK and p38 activation, demonstrating that MAPK and Src/
STAT1 activation take place through separate signaling
pathways.
In summary, the data obtained in the present work highlight
distinct pathways triggered by in-poly(I:C) in two androgen-
resistant PCa cell lines: one mediated by TLR3, leading to apo-
ptosis in an IRF3-independent fashion, and the other one
TLR3-independent,mediated by the cytosolic receptorsMDA5
and RIG-I, IRF3-dependent, and leading to IFN- production.
Moreover IFN-, although it is up-regulated, does not influ-
ence in-poly(I:C)-induced apoptosis.
DISCUSSION
In this study, we report that dsRNA transfection in the most
aggressive androgen-independent prostate cancer cell lines,
PC3 and DU145, exerts an antitumor effect by eliciting differ-
ent responses mediated by distinct receptors and transduction
pathways: apoptosis, via TLR3, and IRF3-dependent IFN--
mediated immunoadjuvant response, via MDA5 in PC3 cells
and via MDA5 and RIGI in DU-145 cells. IFN- is known to be
a keymolecule in antitumoral immune response in various can-
cers, includingPCa (40, 41).Moreover, in different cancermod-
els, IFN-has been shown tomediate poly(I:C)-dependent apo-
ptosis or growth arrest (2, 37, 38). In contrast, in this work, by
using neutralizing antibody against IFNR, we demonstrate that
in-poly(I:C)-induced apoptosis takes place independently of
IFN- in androgen-independent PCa cells. The present data are
also in agreement with our previous work (18) showing that
ex-poly(I:C) induces apoptosis in a TLR3-dependent fashion
independently of IFN- in the androgen-dependent LNCaP
cell line, which is IFN-insensitive. Here we show that
in-poly(I:C) is able to directly trigger apoptosis by a rapid and
transient induction of Src-dependent STAT1 activation, indi-
cating that in-poly(I:C) directly activates STAT1, independ-
ently from IFN-, which is produced afterward. Our data are
consistent with those of Dempoya et al. (42), who reported a
poly(I:C)-induced STAT1 phosphorylation in both a type I
IFN-dependent manner and a type I IFN-independent manner,
depending on the period of time after the introduction of
poly(I:C) into the cells.
So far, only dsRNA cytosolic receptors have been implicated
in the apoptotic effect induced by transfected poly(I:C) or viral
dsRNA in prostate, gastric, breast, and melanoma cancers (20,
43–45). The most specific cytosolic receptor for poly(I:C) was
demonstrated to beMDA5 (46), whichmainlymediates antitu-
mor effects (45). Surprisingly, we found that MDA5 does not
contribute to in-poly(I:C)-induced apoptosis. Accordingly,
Myksiw et al. (47) have shown that RNA species produced dur-
ing virus replication induce the activation of apoptosis in a
PKR-dependent but MDA5- and RIG-I-independent fashion.
With regard to prostate cancer, in particular, it has been dem-
FIGURE 7. JNK and p38 are implicated in in-poly(I:C)-induced apoptosis.
A,Westernblot analysis of phosphorylated JNK (P-JNK) andp38 (P-p38) of PC3
andDU145 cell lysates after in-poly(I:C) treatment at the indicated times.Data
were normalized against -actin. B, apoptosis assayed by PI staining of PC3
andDU145 cells after in-poly(I:C) treatment alone or in combinationwith JNK
inhibitor (SP600125) or p38 inhibitor (SB203580), as indicated. The histo-
grams represent the mean S.D. (error bars) of the percentage of apoptotic
cells of three independent experiments. The exact p values are reported ver-
sus the respective controls (Student’s paired t test): **, p  0.01. C, Western
blot analysis after in-poly(I:C) treatment for phosphorylated JNK and p38 in
whole cell lysates obtained from DN-TLR3 PC3 cells and DU145 cells pre-
treated with Pepinh-TRIF and the respective controls. Data were normalized
against-actin.Data inA andC are representativeof threeWesternblots from
three independent experiments.
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onstrated that an intracellular viral RNA genome from hema-
gglutinating virus of Japan suppressed the viability of PC3 and
DU145 cells with two different mechanisms, Trail- and IRF3-
dependent in PC3 cells and Noxa- and IRF-7-dependent in
DU145 cells, both downstream of cytoplasmic RNA receptor
RIG-I (20). Conversely, in the present paper, by using knock-
down by siRNA or specific pharmacological inhibition of PKR,
MDA5, RIG-I, and MAVS, we excluded the involvement of all
cytosolic receptors in in-poly(I:C)-induced apoptosis. In agree-
ment, we have recently encapsulated poly(I:C) with three cati-
onic liposome formulations with comparable levels in cell
uptake in endocytic vesicles but distinct tendencies to release
gene cargo in the cytosol, and we observed that the release of
poly(I:C) in the cytosol seems not to be critical for induction of
apoptosis in PC3 and DU145 cells (21). In the present study, we
demonstrate, by co-immunolocalization and FACS assays, that
endocytosis was the major mechanism of delivery for in-poly(I:
C), which, at the lowest dose, induces a strong enhancement in
cellular uptake when compared with a 12-fold higher concen-
tration of ex-poly(I:C). Because we observed amarked decrease
of cell viability of PC3 and DU145 cells after in-poly(I:C) com-
pared with ex-poly(I:C), we demonstrated that the relevant
endocytic uptake can greatly favor poly(I:C) binding to endo-
somal TLR3, consequently promoting high levels of apoptosis.
By using a dominant negative TLR3, we show that TLR3 is
crucial for in-poly(I:C)-induced apoptosis compared with
poly(I:C) interaction with cytosolic receptors, suggesting that
the highly efficient poly(I:C) localization in the endosomes after
in-poly(I:C) as compared with ex-poly(I:C) accounts for the
strong apoptotic effect due to the induction of caspase-9 activ-
ity, absent after ex-poly(I:C), and higher caspase-8 activity after
in-poly(I:C) than after ex-poly(I:C) in both PCa cell lines.
Thereafter, we focused our attention on identifying the sig-
naling pathways responsible for in-poly(I:C)-induced apopto-
sis. The role of the Src pathway downstreamof growth factors is
well known. In fact, Src involvement in PDGF- and EGF-medi-
ated tyrosine phosphorylation of STAT1 and STAT3 has been
reported in tumor and normal cells with different biological
activity (48, 49). In this report, we show for the first time the
involvement of the TLR3/Src/STAT1 pathway inmediating in-
FIGURE 8. Implication of Src and STAT1 in apoptosis induced by in-poly(I:C). A, PI staining of PC3 and DU145 cells after 48 h of treatment with in-poly(I:C)
aloneor in combinationwith Src inhibitor (SU66656). Thehistograms represent themean S.D. of apoptotic cells obtained in three independent experiments.
The exact p values are reported versus respective controls (Student’s paired t test): **, p 0.01. B–D, Western blot analysis of whole cell lysates obtained from
PC3 and DU145 cells of the indicated phosphoproteins after the in-poly(I:C) with or without SU66656 treatments for different times. Data were normalized
against -actin. Data in B–D are representative of three Western blots from three independent experiments.
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poly(I:C)-induced apoptosis. In fact, Src inhibition blocks apo-
ptosis concurrently with the inhibition of STAT1 activation but
does not affect IRF3 phosphorylation, in agreement with the
notion that in our model IRF3 is downstream of the MDA5/
RIGI pathways and is not involved in apoptosis. Interestingly, it
has been demonstrated that the tyrosine kinase Src is activated
also by extracellular dsRNA, which triggers its association with
TLR3 essential for dsRNA-elicited IRF3 and STAT1 activation
(10, 50).
Moreover, by using MAPK-specific inhibitors and TLR3
knockdown cells, we observed that p38 and JNK MAPK path-
ways controlled TLR3-mediated cell death in PC3 and DU145
cells upon in-poly(I:C) stimulation. Accordingly, a role for p38
has been demonstrated also in TLR2-dependent apoptosis (51),
and inhibition of p38 MAPK activity alleviates apoptosis
induced by Japanese encephalitis virus (52). In regard to the
interaction between theMAPK and Src pathways in ourmodel,
our data show that the inhibition of Src does not affect JNK and
p38 activation, in agreement with Johnsen et al. (10), who
showed that MAPK activation in response to dsRNA occurs
through separate signaling pathways that diverge upstream
of Src.
Besides its key role in antiviral immunity, IRF3 activation by
virus infection is essential for triggering a direct apoptotic
response, as manifested by the fact that infected cells are not
killed in the absence of IRF3 and become persistently infected
(53–55). In agreement, we have recently demonstrated that
IRF3 mediates apoptosis in response to dsRNA in androgen-
sensitive PCa cells (56) as well as, as previously observed, in
melanoma and fibrosarcoma cells (57). Conversely, in this
work, we found that in-poly(I:C)-induced apoptosis is com-
pletely independent of IRF3, as shown by using genetic and
pharmacological approaches. In our model, IRF3 is involved
exclusively in MDA5- and RIG-I-dependent up-regulation of
IFN-, which in turn accounts for MDA5, RIG-I, and TLR3
protein increase. This demonstrates that IRF3-mediated IFN-
production is dependent on an intact MDA5/RIGI/MAVS/
IRF3 axis, but, at least in PC3 cells that express type I IFN recep-
tor, the subsequent expansion of antiviral/immunoadjuvant
response is driven by the binding of newly synthesized IFN-
on its receptor, which acts in an autocrine fashion to up-regu-
late the expression of interferon-stimulated genes, such as all of
the dsRNA receptors, as reviewed previously (39). Further,
MDA5 expressionwas shown to be virus-inducible in cells lack-
ing the IFN receptor, suggesting that RLH expression could be
driven by a direct virus-inducible signal (58). Accordingly, we
found an IRF3-dependent increase of dsRNA receptors after
in-poly(I:C) in DU145 cells, although they do not express the
type I interferon receptor. Recently, Zhou et al. (59) reported
that in different cell lines, the activation of TLR3 leading to IFN
production can be triggered either by naked poly(I:C) or only by
transfected poly(I:C). In agreement, our data enforce the notion
that the delivery of poly(I:C) is a key factor in influencing spe-
cific antiviral responses according to the target cell type.
Collectively, our data show two different in-poly(I:C)-acti-
vated tumor suppressor pathways leading to apoptosis and
to the production of antiviral/immunoadjuvant molecules.
Because many of the efforts regarding anti-cancer drug devel-
opment employ encapsulation of antitumor drugs in order to
reduce the drug dosage required (60), our data may be of clin-
ical relevance in order to target tumor cells both by inducing
apoptosis and by immunologically mediated antitumor
responses.
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